Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Albany Medical Center
mi
from
Albany, NY
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
University Hospital Cleveland Medical Center
mi
from
Cleveland, OH
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
University Hospital Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Penn State University
mi
from
State College, PA
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Penn State University
mi
from
State College, PA
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Duke University
mi
from
Durham, SC
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Duke University
mi
from
Durham, SC
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
University of Virginia
mi
from
Charlottesville, VA
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
OLV Ziekenhuis Aalst
mi
from
Aalst,
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
OLV Ziekenhuis Aalst
mi
from
Aalst,
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Stanford University
mi
from
Stanford, CA
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Cleveland Clinic Florida
mi
from
Weston, FL
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Franciscan
mi
from
Indianapolis, IN
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Franciscan
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Indiana University
mi
from
Indianapolis, IN
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Medical University SC (MUSC)
mi
from
Worcester, MA
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Medical University SC (MUSC)
mi
from
Worcester, MA
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
University of Massachusetts
mi
from
Worcester, MA
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Spectrum Health
mi
from
Grand Rapids, MI
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Spectrum Health
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
New York University
mi
from
New York, NY
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
Cleveland Clinic
mi
from
Cleveland, OH
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated:  3/29/2018
University of Vermont
mi
from
Burlington, VT
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Status: Enrolling
Updated: 3/29/2018
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer or Metastatic Melanoma
Pilot Study to Identify Biomarkers That May Predict Response to High Dose IL-2
Status: Enrolling
Updated:  3/29/2018
UNMC Eppley Cancer Center at the University of Nebraska Medical Center
mi
from
Omaha, NE
Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer or Metastatic Melanoma
Pilot Study to Identify Biomarkers That May Predict Response to High Dose IL-2
Status: Enrolling
Updated: 3/29/2018
UNMC Eppley Cancer Center at the University of Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer: A Phase II Study #108181
Status: Enrolling
Updated:  3/29/2018
Lifespan Hospitals
mi
from
Providence, RI
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer: A Phase II Study #108181
Status: Enrolling
Updated: 3/29/2018
Lifespan Hospitals
mi
from
Providence, RI
Click here to add this to my saved trials
Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
Efficacy of a Novel, High-Sensitivity, Portable, Hand-Held Gamma Camera Used Intraoperatively for Identification of Sentinel Lymph Nodes With Lymphoscintigraphy
Status: Enrolling
Updated:  3/29/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
Efficacy of a Novel, High-Sensitivity, Portable, Hand-Held Gamma Camera Used Intraoperatively for Identification of Sentinel Lymph Nodes With Lymphoscintigraphy
Status: Enrolling
Updated: 3/29/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/30/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/30/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
Status: Enrolling
Updated:  3/30/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
Status: Enrolling
Updated: 3/30/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Soy Treatment for High-risk Women
Status: Enrolling
Updated:  3/30/2018
University of Southern California
mi
from
Los Angeles, CA
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Soy Treatment for High-risk Women
Status: Enrolling
Updated: 3/30/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy
Prospective, Double Arm, Comparative Study for the Evaluation of Postoperative Pain, QOL, and Determination of Inflammatory Markers In Patients Undergoing Robotics Versus Open Laparotomy Approach for Staging of Endometrial Cancer
Status: Enrolling
Updated:  3/30/2018
Ohio State University
mi
from
Columbus, OH
Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy
Prospective, Double Arm, Comparative Study for the Evaluation of Postoperative Pain, QOL, and Determination of Inflammatory Markers In Patients Undergoing Robotics Versus Open Laparotomy Approach for Staging of Endometrial Cancer
Status: Enrolling
Updated: 3/30/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based Regimen
Status: Enrolling
Updated:  3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based Regimen
Status: Enrolling
Updated: 3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer
Evaluation of Combination Checkpoint Inhibitor Plus Targeted Inhibitor (Erlotinib or Crizotinib) for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer: Phase Ib With Expansion Cohorts
Status: Enrolling
Updated:  3/30/2018
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer
Evaluation of Combination Checkpoint Inhibitor Plus Targeted Inhibitor (Erlotinib or Crizotinib) for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer: Phase Ib With Expansion Cohorts
Status: Enrolling
Updated: 3/30/2018
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases
An Observation, Open Label Study of Alpharadin (Radium 223) in Patients With Castrate Resistant Prostate Cancer Bone Metastases
Status: Enrolling
Updated:  3/30/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases
An Observation, Open Label Study of Alpharadin (Radium 223) in Patients With Castrate Resistant Prostate Cancer Bone Metastases
Status: Enrolling
Updated: 3/30/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  3/30/2018
HonorHealth Research Institute
mi
from
Scottsdale, AZ
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 3/30/2018
HonorHealth Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  3/30/2018
Chao Family Comprehensive Cancer Center of
mi
from
Orange, CA
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 3/30/2018
Chao Family Comprehensive Cancer Center of
mi
from
Orange, CA
Click here to add this to my saved trials
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  3/30/2018
Dana-Farber Cancer Inst
mi
from
Boston, MA
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 3/30/2018
Dana-Farber Cancer Inst
mi
from
Boston, MA
Click here to add this to my saved trials
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  3/30/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 3/30/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  3/30/2018
Massachusetts General Hospital
mi
from
Boston, MA
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 3/30/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  3/30/2018
New York University
mi
from
New York, NY
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 3/30/2018
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
Sonography Compared With MRI in Pre-Operative Evaluation of Patients With Breast Cancer to Determine Extent of Breast Disease
Status: Enrolling
Updated:  3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
Sonography Compared With MRI in Pre-Operative Evaluation of Patients With Breast Cancer to Determine Extent of Breast Disease
Status: Enrolling
Updated: 3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
Detroit, MI
Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
Nashville, TN
Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
Phase II Trial of Low Toxicity GVHD Prevention and Enhanced Immune Recovery With Tacrolimus, Bortezomib and Thymoglobulin® TBT
Status: Enrolling
Updated:  3/30/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
Phase II Trial of Low Toxicity GVHD Prevention and Enhanced Immune Recovery With Tacrolimus, Bortezomib and Thymoglobulin® TBT
Status: Enrolling
Updated: 3/30/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
UAB Cancer Center
mi
from
Birmingham, AL
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
UAB Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
University of Chicago
mi
from
Chicago, IL
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research
mi
from
Baltimore, MD
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Baylor College of Medicine, Lester and Sue Smith Breast Center
mi
from
Houston, TX
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Baylor College of Medicine, Lester and Sue Smith Breast Center
mi
from
Houston, TX
Click here to add this to my saved trials
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated:  4/2/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated: 4/2/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated:  4/2/2018
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated: 4/2/2018
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated:  4/2/2018
City of Hope South Pasadena
mi
from
South Pasadena, CA
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated: 4/2/2018
City of Hope South Pasadena
mi
from
South Pasadena, CA
Click here to add this to my saved trials
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated:  4/2/2018
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated: 4/2/2018
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated:  4/2/2018
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies
Status: Enrolling
Updated: 4/2/2018
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Status: Enrolling
Updated:  4/2/2018
Mary Crowley Cancer Research Centers
mi
from
Dallas, TX
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Status: Enrolling
Updated: 4/2/2018
Mary Crowley Cancer Research Centers
mi
from
Dallas, TX
Click here to add this to my saved trials